2013
DOI: 10.1111/petr.12189
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal gammopathy of undetermined significance in pediatric kidney transplant: A possible role of Epstein‐Barr virus

Abstract: MG is a common event of hematologic malignancies. There are many papers regarding kidney transplantation patients with MGUS in adults, while data in pediatrics are scarce. The etiology and clinical significance of MGUS are unclear both in adults and children. Immunosuppressive drugs, graft antigenicity, and viral infection could play a possible role. The viruses most frequently implicated seem to be EBV or CMV in particular, but their role has to be defined better. However, many investigators have emphasized a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Solid organ transplant requires long‐term use of immunosuppression post‐engraftment, which is associated with many risks overlapping those described above, including hematologic malignancies and post‐transplant lymphoproliferative disease (PTLD), opportunistic infections, SRE, and VTE. MGUS‐affected patients usually are not excluded from transplantation; however, data on long‐term outcomes are lacking and limited to single institution studies with relatively small patient numbers . We hypothesized that patients with the precancerous condition, MGUS, are at heightened risk for these post‐transplant complications.…”
mentioning
confidence: 99%
“…Solid organ transplant requires long‐term use of immunosuppression post‐engraftment, which is associated with many risks overlapping those described above, including hematologic malignancies and post‐transplant lymphoproliferative disease (PTLD), opportunistic infections, SRE, and VTE. MGUS‐affected patients usually are not excluded from transplantation; however, data on long‐term outcomes are lacking and limited to single institution studies with relatively small patient numbers . We hypothesized that patients with the precancerous condition, MGUS, are at heightened risk for these post‐transplant complications.…”
mentioning
confidence: 99%